Keeping Up with the Guidelines: Recommendations and Controversies in Sexually Transmitted Infection (STI) Management

Program Description

Join IAS–USA for a highly anticipated and timely virtual symposium on the management of sexually transmitted infections (STIs) and HIV. New practice-changing data are anticipated in the next 6 months, and this course is specifically designed to offer a comprehensive update on the prevention and treatment of STIs and HIV in a half-day course format that balances didactic content, clinically relevant case-based panel discussion, and practical clinical applications.

Assessment of Needs

Rapid advances in STI and HIV disease management require the ongoing attention of practitioners involved in direct patient care. With the evolution of treatment protocols and the emergence of new challenges in STI and HIV care, this course will address the implications of new information on strategies for the clinical management of STIs and HIV.

Learning Objectives

After participating in the activity, learners will be able to:

• Apply new research data to improve patient education and counseling on STIs and HIV prevention and treatment
• Identify the clinical manifestations of common STIs in people with HIV
• Discuss challenges related to doxycycline postexposure prophylaxis (doxyPEP) for the prevention of chlamydia, gonorrhea, and syphilis
• Interpret serologic test results for syphilis and manage challenging clinical situations of serologic titers that do not respond appropriately to therapy
• Describe the latest evidence-based treatment guidelines for common STIs, including clinical implications and antimicrobial resistance

Preliminary Topics

The following issues in HIV and STIs will be covered:

• Updates on hepatitis B coinfection: challenging serology and treatment approaches
• Treatment and prevention of syphilis
• Updates on chlamydia management, including vaccines for prevention of sexually transmitted infections
• Management implications of antimicrobial resistant gonorrhea
• Congenital syphilis during pregnancy
• HIV and PrEP

Conflicts of Interest

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.  

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” 

IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenters and planners/reviewers will be available in the esyllabus and in the slides prior to the presentation of educational content. 

Registration

Who Should Attend

This course is designed for physicians who are actively involved in the medical care of people with HIV infection and:

• Have a solid, working knowledge of HIV disease management
• Provide comprehensive or specialty care for patients with HIV infection
• Are currently active in HIV research

This activity is also relevant to nurse practitioners, registered nurses, physician assistants, registered pharmacists, and other health professionals.

Representatives and employees of commercial companies (eg, pharmaceutical, diagnostic, medical products, advertising, insurance, investment, and communications firms) must contact the IAS–USA regarding registration procedures.

Cancellation Policy

Cancellation requests must be made 7 or more days before the date of an activity. All refunds will be processed minus a $15.00 processing charge. Regrettably, any cancellation requests received within a week before the course will not be eligible for the partial refund.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Points